Boston Partners’s Axcelis ACLS Stock Holding History
Bought
Maintained
Sold
Other funds holding ACLS
RP
Boston Partners's ACLS Position: Q2 2026 in Review
Boston Partners reduced its Axcelis (ACLS) stake by 11% in Q2 2026, selling an estimated $5.39M and leaving 303,929 shares worth $55.7M. The position accounts for 0.05% of the portfolio, ranked #266.
Boston Partners first reported a position in ACLS in Q1 2020 and has held it in 22 quarters since. 441 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.
- Boston Partners held 303,929 shares of Axcelis worth $55.7M as of Q2 2026.
- Boston Partners sold 36,346 Axcelis shares in Q2 2026, an estimated $5.39M.
- Axcelis made up 0.05% of Boston Partners's portfolio in Q2 2026, its #266 holding.
- Boston Partners first reported a position in Axcelis in Q1 2020 and has held it in 22 quarters since.
- 441 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.
Based on Boston Partners's 13F filing for Q2 2026, filed 4 Aug 2026.